BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10128726)

  • 1. A successful community hospital program for monitoring adverse drug reactions.
    Saine DR
    Top Hosp Pharm Manage; 1992 Jul; 12(2):19-30. PubMed ID: 10128726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting adverse drug reactions is everyone's business: an adverse drug reaction reporting program that works.
    Burkhardt ME; Ripepe SD
    Top Hosp Pharm Manage; 1992 Jul; 12(2):31-9. PubMed ID: 10128727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A team approach to adverse drug reaction surveillance: success at a tertiary care hospital.
    Saltiel E; Johnson E; Shane R
    Hosp Formul; 1995 Apr; 30(4):226-8, 231-2. PubMed ID: 10141866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the discharge process as one method to capture adverse drug reaction reports.
    Gee MA; Daniels BW
    Top Hosp Pharm Manage; 1992 Jul; 12(2):75-81. PubMed ID: 10128731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy-coordinated, multidisciplinary adverse drug reaction program.
    Swanson KM; Landry JP; Anderson RP
    Top Hosp Pharm Manage; 1992 Jul; 12(2):49-59. PubMed ID: 10136574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criteria-based adverse drug reaction reporting and the use of a relational database.
    Hatton RC
    Top Hosp Pharm Manage; 1992 Jul; 12(2):40-8. PubMed ID: 10128728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the development of a multidisciplinary adverse drug reaction committee.
    Etzel JV; Brocavich JM; Rousseau M
    Hosp Pharm; 1995 Dec; 30(12):1083-7. PubMed ID: 10153655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved reporting of adverse drug reactions.
    Kimelblatt BJ; Young SH; Heywood PM; Mandala AR; Gendelman S; Mehl B
    Am J Hosp Pharm; 1988 May; 45(5):1086-9. PubMed ID: 3400650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital pharmacy compliance with JCAHO standards and ASHP guidelines for reporting adverse drug reactions.
    Tyler LS; Nickman NA
    Am J Hosp Pharm; 1992 Apr; 49(4):845-50. PubMed ID: 1595720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ADR surveillance program: increasing quality, number of incidence reports.
    Orsini MJ; Orsini PA; Thorn DB; Gallina JN
    Formulary; 1995 Aug; 30(8):454-61. PubMed ID: 10151733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adapting a commercially available software program to improve ADR reporting.
    Ries AJ; Kraynak MA
    Formulary; 1995 Nov; 30(11):697-8, 703-4. PubMed ID: 10152873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-assisted use of tracer antidote drugs to increase detection of adverse drug reactions: a retrospective and concurrent trial.
    Dalton-Bunnow MF; Halvachs FJ
    Hosp Pharm; 1993 Aug; 28(8):746-9, 752-5. PubMed ID: 10127575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions.
    Gilroy GW; Scollins MJ; Gay CA; Harry DJ; Giannuzzi DF
    Am J Hosp Pharm; 1990 Jun; 47(6):1327-33. PubMed ID: 2368726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reaction program using pharmacist and nurse monitors.
    Miwa LJ; Randall RJ
    Hosp Formul; 1986 Nov; 21(11):1140-3, 1146. PubMed ID: 10279322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality improvement in the use of medications through a drug use evaluation service.
    Stevenson JG; Bakst CM; Zaran FK; Rybak MJ; Smolarek RT; Alexander MR
    Top Hosp Pharm Manage; 1992 Oct; 12(3):47-56. PubMed ID: 10128747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective dosage adjustment program in a geriatric population.
    Guharoy SR
    Top Hosp Pharm Manage; 1994 Apr; 14(1):67-72. PubMed ID: 10171827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A continuous quality improvement team approach to adverse drug reaction reporting.
    Flowers P; Dzierba S; Baker O
    Top Hosp Pharm Manage; 1992 Jul; 12(2):60-7. PubMed ID: 10128729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of standardized screening procedures to identify adverse drug reactions.
    Koch KE
    Am J Hosp Pharm; 1990 Jun; 47(6):1314-20. PubMed ID: 2368724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidisciplinary adverse drug reaction surveillance program.
    Prosser TR; Kamysz PL
    Am J Hosp Pharm; 1990 Jun; 47(6):1334-9. PubMed ID: 2368727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Program coordinated by a drug information service to improve adverse drug reaction reporting in a hospital.
    Michel DJ; Knodel LC
    Am J Hosp Pharm; 1986 Sep; 43(9):2202-5. PubMed ID: 3766573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.